However, studies suggest that reduced IL-10 expression permits increased angiogenesis and heightened activity of VEGF, IL-1β, TNF-α, IL-6, and NF-κB, ultimately enhancing tumor growth. The gene discussed is NFKB1; the disease is neoplasm.